Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass.
Wessel
D L
DL
Cardiac Intensive Care Unit, Children's Hospital, Harvard Medical School, Boston, MA 02215.
D000109:Acetylcholine / Q000494:pharmacology / Q000627:therapeutic use*; D000280:Administration, Inhalation; D002315:Cardiopulmonary Bypass; D002648:Child; D006152:Cyclic GMP / Q000097:blood; D004359:Drug Therapy, Combination; D004727:Endothelium / Q000187:drug effects; D006330:Heart Defects, Congenital / Q000150:complications / Q000601:surgery*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007261:Infusions, Intra-Arterial; D009569:Nitric Oxide / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects
D009569:Nitric Oxide; D006152:Cyclic GMP; D000109:Acetylcholine